Posts

Showing posts with the label Venous thromboembolism (VTE) Market

Venous thromboembolism (VTE) Market: Global Company Forecast and Opportunity Analysis 2020-2028

Image
Venous thromboembolism (VTE) Venous thromboembolism (VTE) is a disorder in which a blood clot forms in the deep veins of the leg, groin, or arm (also known as DVT) and travels through the circulation, eventually landing in the lungs (known as pulmonary embolism, PE). VTE is a severe, perhaps fatal medical disease that results from the combination of DVT and PE. The Venous thromboembolism (VTE) Market  is a major source of death and disability around the world. According to the WTD steering committee's rigorous scientific analysis, 10 million instances of VTE occur annually in low, middle, and high-income nations. Treatment options for venous thromboembolism include anticoagulant and thrombolytic therapy (VTE). The anticoagulant medication stops new clots from forming and allows the patient's own fibrinolytic systems to dissolve the current clot. Heparin or low-molecular-weight heparin (LMWH) should be used as an anticoagulant inpatient drug, followed by the administration of an...